|
|
Volumn 102, Issue 9, 2000, Pages
|
|
Use of targeted anticytokine treatments in heart failure.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL RESPONSE MODIFIER;
IMMUNOGLOBULIN G;
LEUKOCYTE ANTIGEN;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
TUMOR NECROSIS FACTOR RECEPTOR 2;
CHEMISTRY;
CONGESTIVE HEART FAILURE;
DRUG ANTAGONISM;
HUMAN;
NOTE;
ANTIGENS, CD;
BIOLOGICAL RESPONSE MODIFIERS;
HEART FAILURE, CONGESTIVE;
HUMANS;
IMMUNOGLOBULIN G;
RECEPTORS, TUMOR NECROSIS FACTOR;
RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;
TUMOR NECROSIS FACTOR-ALPHA;
MLCS;
MLOWN;
|
|
EID: 0034730041
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/01.cir.102.9.e65 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
